News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 7:58:30 pm RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023 InvestorPlace
2024-03-21 1:22:35 pm Regulus: Q4 Earnings Snapshot Associated Press Finance
2024-03-21 1:5:0 pm Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates PR Newswire
2024-03-14 9:7:0 am Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More Zacks
2024-03-13 9:9:0 am Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study Zacks
2024-03-12 3:32:0 am Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity PR Newswire
2024-03-12 3:30:0 am Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire
2024-01-02 1:5:0 pm Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information